SecBot SecBot
8-K ·Filed Apr 21, 2026

ZEOX

Zeo ScientifiX, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001829126-26-003684
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor upcoming quarterly filings for revenue or enrollment trends that may validate the commercial impact of this training initiative; for now, treat as brand-building with no immediate financial implications.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ZEOX ▼ -7.77% at T+60d
NEUTRAL call -7.77% · α vs SPY -14.67% · entry $1.93 → $1.78
Entry = T+0 close
Apr 21, 2026
via day close
T+1d
-4.30%
call -4.30% · α -5.32%
$1.85
settled 6mo ago
T+5d
-5.44%
call -5.44% · α -6.52%
$1.83
settled 6mo ago
T+20d
+9.33%
call +9.33% · α +4.41%
$2.11
settled 5mo ago
T+60d
-7.77%
call -7.77% · α -14.67%
$1.78
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Zeo ScientifiX announced it has trained over 500 clinicians through its monthly Masterclass series in regenerative biologics, highlighting growing demand for compliant education in the field. The program, held at Nova Southeastern University, averages over 70 attendees monthly.

Key Facts

  • Zeo ScientifiX trained over 500 clinicians through its Masterclass series.
  • The Masterclass is a one-day intensive held monthly at Nova Southeastern University’s Center of Innovation.
  • Each session averages over 70 attendees and focuses on regulatory compliance, evidence-based science, and clinical integration of regenerative biologics.
  • The announcement is promotional and contains forward-looking statements.

Financial Impact

No financial impact disclosed; this is a qualitative milestone announcement.

Risk Factors

  • Forward-looking statements may not materialize.
  • No direct financial or operational metrics were disclosed to quantify business impact.

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-003684
Document: zeoscientifix_ex99-1.htm0001829126-26-003684
Document: 0001829126-26-003684-index-headers.html0001829126-26-003684
Document: 0001829126-26-003684-index.html0001829126-26-003684
Document: 0001829126-26-003684.txt0001829126-26-003684
14 reports for ZEOX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +13.87%Apr 9, 2026
Filters
Rows
Reports for ZEOX — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 5/10
—awaiting T+20——
Sep 15, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$1.36 $1.15▼ −15.44%▼ −18.42%$1.57 (+15.44%)
Sep 1, 2026
7w ago
8-K
NEUTRAL ★ 2/10
$1.20 $1.39▲ +15.83%▲ +14.65%$1.57 (+30.83%)
Aug 4, 2026
11w ago
8-K
NEUTRAL ★ 2/10
$1.40 $1.20▼ −14.16%▼ −12.93%$1.57 (+12.30%)
Jul 21, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$1.69 $1.55▼ −8.28%▼ −10.85%$1.57 (−7.10%)
Jul 8, 2026
15w ago
8-K
BULLISH ★ 5/10
$1.80 $1.40▼ −22.33%▼ −25.61%$1.57 (−12.78%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 1/10
$1.77 $1.65▼ −6.78%▼ −4.59%$1.57 (−11.30%)
Jun 16, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$1.72 $1.94▲ +12.79%▲ +11.93%$1.57 (−8.72%)
Jun 9, 2026
19w ago
8-K
NEUTRAL ★ 2/10
$1.67 $1.80▲ +7.78%▲ +6.39%$1.57 (−5.99%)
May 27, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$1.85 $1.70▼ −8.11%▼ −6.21%$1.57 (−15.14%)
Showing 10 of 14

US Market Status

Market Open — Closes in 5h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026